Healing the Future

Abdi İbrahim harnesses the power of science and technology to integrate sustainability into its business processes, healing the future of the ecosystem, people and business.

Our approach

We aim for the transformation we have begun — driven by our vision of international leadership and our commitment to “Healing the Future” — to support meaningful changes that shape and heal the world. Our sustainability journey centres on three key areas: the future of the ecosystem, people and business.

Our strategy, designed from a long-term value-creation perspective, is underpinned by targets for 2030, 2040 and 2050. We implement it in line with our strategic priorities, base our operations on transparency, fairness, responsibility and accountability, and foster collaboration on the path to our goals.

Value chain

01

Product development and R&D

  • Developing innovative products
  • Bioequivalence studies
  • Branded product development processes
  • Finding new treatment methods
  • Clinical research to improve or compare existing treatment methods
  • Evaluating and reporting product risks and benefits
  • Exploring packaging alternatives with low environmental impact
TL 192 million R&D expenditure
02

Material supply

  • Raw material supply and inventory management
  • Managing the procurement of raw materials, materials and production equipment from suppliers
  • Exploring sustainable packaging alternatives
  • Supplier evaluation processes
2,018 suppliers
03

Registration

  • Preparing registration dossiers for medicinal products for human use
  • Managing registration processes
  • Preparing applications and obtaining approvals for cosmetics, medical devices and food supplements
  • Supporting product launch procedures
148 products registered across all countries in 2022
04

Production of pharmaceuticals and consumer health products

  • Production facilities in 3 countries: Türkiye, Kazakhstan, Algeria
  • Production services for national and international companies
  • Esenyurt production complex powered by 100% renewable electricity
05

Product packaging

  • Reducing packaging materials
  • Exploring packaging alternatives with low environmental impact
−28% packaging GHG emissions per product; 179 t of materials saved
06

Storage and distribution

  • Optimising storage and distribution processes
  • Abdi İbrahim Techno-Logistics Centre: all operations, including material handling, are computer-controlled with no manual intervention; 1,200 pallets moved daily
  • 2022: 38,000+ EUR-pallets shipped to 26 companies under contract manufacturing
  • 2022: approx. 87,000 pallets handled in the finished-goods warehouse
2022: approx. 7,500 EUR-pallets of medicines exported to 53 countries
07

Marketing and sales

  • 228 brands and 458 products in Türkiye
  • 120 brands and 220 products in international markets
  • Exports to more than 70 countries
  • Collaboration with more than 30 licensors
  • Abdi İbrahim teams in 18 countries
2,760-strong marketing and sales team
08

End of product life cycle

  • Packaging reduction
  • Exploring biodegradable packaging alternatives

2022 data.

Contributing to the UN Sustainable Development Goals

Guided by the UN Sustainable Development Goals (SDGs) — the universal call to end poverty, protect the planet and ensure peace and prosperity for all — Abdi İbrahim defined its sustainability actions based on a materiality analysis conducted in 2020. Its material topics are grouped so as to contribute to nine SDGs simultaneously within the UN 2030 Agenda.

Supported SDGs

SDGs 5, 6, 7, 8, 9, 10, 12, 13 and 17

Topics of very high importance

  • R&D and innovation
  • Biotechnology products
  • Localisation
  • Stakeholder engagement
  • Talent management

Topics of high importance

  • Climate change and energy management
  • Waste management
  • Drug safety and side effects
  • Intellectual property and patents
  • Business ethics and transparency
  • Occupational health and safety

Sustainability goals

On the sustainability journey we set out on with our international leadership vision and the goal of “Healing the Future”, we aim to heal the future of our ecosystem, business and people.

2030
Targets
  • Become a carbon-neutral company
  • Reduce Scope 1 and 2 greenhouse gas emissions by 60% against the 2020 base year
  • Reduce Scope 3 greenhouse gas emissions by 45% against the 2020 base year
  • Increase sustainable packaging for consumer health products by 5%
  • Measure the impact of investments (SROI)
  • Raise the share of women in management (manager and above) to 45%
  • Raise average training hours per employee to 30
  • Raise the share of local suppliers in Türkiye operations to 80%
  • Collect sustainability data from critical suppliers accounting for 80% of direct purchasing volume
2040
Targets
  • Reduce Scope 1 and 2 emissions by 75% against the 2020 base year
  • Reduce all Scope 3 emissions by 60% against the 2020 base year
  • Increase impact-oriented collaboration
  • Implement programmes to improve critical suppliers’ sustainability performance
2050
Targets
  • Achieve net zero emissions
  • Deliver social investment projects whose impact exceeds the investment made
  • Raise the share of women in management to 50%
  • Increase investment in the future of the business

Focus areas

Decarbonisation

Acting towards net zero emissions across the value chain.

Good for employees

Developing the competences the industry will need in the future; upholding diversity, equality and inclusion.

Leadership

Local production “starting from the cell” and taking our leadership from Türkiye to the international level through a broad portfolio and investment in biotechnology.

Product sustainability

Applying circular economy principles from the design stage.

Good for people

Supporting scientific awareness and societal well-being through social innovation, volunteering and social investment.

Responsible supply chain

Applying responsible purchasing principles at every stage of the supply chain.

Circularity

Recycling medicine and consumer health product packaging after use.

Ethics, transparency and compliance

Operating transparently, fairly, responsibly and accountably.

Collaboration

Impact-oriented collaboration on the path to our goals.

Innovation